Category: Oncology

Meet NanoString Scientists at the AMP 2019 Annual Meeting & Expo

When Elaine Lyon, Ph.D., a scientist on the board of the Association for Molecular Pathology (AMP) was asked why she is involved with AMP, its activities and initiatives, she quoted the famous Captain James T. Kirk from Star Trek and...

/ November 4, 2019

The challenges of profiling miRNA Biomarkers from FFPE and Biofluid Samples

In 1993, Dr. Victor Ambros’ lab discovered a small RNA sequence, Lin-4, that was “essential for the normal temporal control of diverse postembryonic developmental events in C. elegans”. Sequence analysis revealed that the molecule was 22 nucleotides long and didn’t...

/ October 21, 2019

The bench side of organ transplant: Challenges and solutions

“It is infinitely better to transplant a heart than bury it to be devoured by worms,” said Dr. Christiaan Barnard, the father of the heart transplant. It’s hard to disagree with this statement! Organ transplant today is an established treatment...

/ October 7, 2019

Aiming at the Achilles’ heel of cancer: multiplexed lung cancer fusion detection without FISH or NGS

Lung cancer is the most commonly diagnosed cancer worldwide, and the leading cause of cancer deaths in the United States. It is generally divided into two types, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), based on...

/ September 23, 2019

miRNA Profiling in Malignant Melanoma: Making “Australia’s National Cancer” Obsolete.

Australia is a sun-worshipping country, the world capital for beautiful beaches, athletic surfers, cute marsupials, and the occasional weird-looking animal. But it is also the capital for something less pleasant: skin cancer. In fact, at least two in three Australians...

/ August 12, 2019